Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.
2.

Eldecalcitol (ED-71), an analog of 1α,25-dihydroxyvitamin D3 as a potential anti-cancer agent for oral squamous cell carcinomas.

Shintani T, Rosli SN, Takatsu F, Choon YF, Hayashido Y, Toratani S, Usui E, Okamoto T.

J Steroid Biochem Mol Biol. 2016 Nov;164:79-84. doi: 10.1016/j.jsbmb.2015.09.043. Review.

PMID:
26444325
3.

Comparison of the effects of 12 months of monthly minodronate monotherapy and monthly minodronate combination therapy with vitamin K2 or eldecalcitol in patients with primary osteoporosis.

Ebina K, Noguchi T, Hirao M, Kaneshiro S, Tsukamoto Y, Yoshikawa H.

J Bone Miner Metab. 2016 May;34(3):243-50. doi: 10.1007/s00774-015-0710-2. Review.

PMID:
26303222
4.

Vitamin D3 analogs for the treatment of osteoporosis.

Hagino H.

Can J Physiol Pharmacol. 2015 May;93(5):327-32. doi: 10.1139/cjpp-2014-0419. Review.

PMID:
25853632
5.

[Current Topics on Vitamin D. Treatment of osteoporosis with eldecalcitol: Its therapeutic efficacy and adverse effect on renal function].

Takeuchi Y.

Clin Calcium. 2015 Mar;25(3):425-32. doi: CliCa1503425432. Review. Japanese.

PMID:
25716816
6.

[Current Topics on Vitamin D. The role of active forms of vitamin D in regulation of bone remodeling].

Nakamichi Y, Takahashi N.

Clin Calcium. 2015 Mar;25(3):395-402. doi: CliCa1503395402. Review. Japanese.

PMID:
25716813
7.

[Current Topics on Vitamin D. Protein interaction and biological action of active vitamin D compounds].

Ono Y.

Clin Calcium. 2015 Mar;25(3):387-94. doi: CliCa1503387394. Review. Japanese.

PMID:
25716812
8.

Vitamin D analogs and bone: preclinical and clinical studies with eldecalcitol.

Matsumoto T, Takano T, Saito H, Takahashi F.

Bonekey Rep. 2014 Mar 5;3:513. doi: 10.1038/bonekey.2014.8. Review.

9.

[Recent progress and problem of treatment with active vitamin D].

Fukumoto S.

Clin Calcium. 2014 Jan;24(1):53-8. doi: CliCa14015358. Review. Japanese.

PMID:
24369280
10.

Eldecalcitol replaces endogenous calcitriol but does not fully compensate for its action in vivo.

Saito H, Harada S.

J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:189-96. doi: 10.1016/j.jsbmb.2013.11.013. Review.

11.

Eldecalcitol improves mechanical strength of cortical bones by stimulating the periosteal bone formation in the senescence-accelerated SAM/P6 mice - a comparison with alfacalcidol.

Shiraishi A, Sakai S, Saito H, Takahashi F.

J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:119-23. doi: 10.1016/j.jsbmb.2013.10.024. Review.

PMID:
24189542
12.

Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment.

Ono Y.

J Steroid Biochem Mol Biol. 2014 Jan;139:88-97. doi: 10.1016/j.jsbmb.2013.10.007. Review.

PMID:
24139874
13.

Eldecalcitol for the treatment of osteoporosis.

Noguchi Y, Kawate H, Nomura M, Takayanagi R.

Clin Interv Aging. 2013;8:1313-21. doi: 10.2147/CIA.S49825. Review.

14.

CYP24A1 as a potential target for cancer therapy.

Sakaki T, Yasuda K, Kittaka A, Yamamoto K, Chen TC.

Anticancer Agents Med Chem. 2014 Jan;14(1):97-108. Review.

PMID:
23869781
15.

[Fall risk and fracture. Vitamin D and falls/fractures].

Miyakoshi N.

Clin Calcium. 2013 May;23(5):695-700. doi: CliCa1305695700. Review. Japanese.

PMID:
23628682
16.

Eldecalcitol: newly developed active vitamin D(3) analog for the treatment of osteoporosis.

Hagino H.

Expert Opin Pharmacother. 2013 Apr;14(6):817-25. doi: 10.1517/14656566.2013.778825. Review.

PMID:
23477453
17.

Synthesis of 14-epi-2α-hydroxypropoxy-1α,25-dihydroxy-19-nortachysterol and its hVDR binding.

Sawada D, Tsukuda Y, Saito H, Takagi K, Kakuda S, Takimoto-Kamimura M, Ochiai E, Takenouchi K, Kittaka A.

J Steroid Biochem Mol Biol. 2013 Jul;136:27-9. doi: 10.1016/j.jsbmb.2012.11.014. Review.

PMID:
23246987
18.

Mechanism of inhibitory action of eldecalcitol, an active vitamin D analog, on bone resorption in vivo.

Takahashi N.

J Steroid Biochem Mol Biol. 2013 Jul;136:171-4. doi: 10.1016/j.jsbmb.2012.11.010. Review.

PMID:
23220095
19.

Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone.

Saito H, Takeda S, Amizuka N.

J Steroid Biochem Mol Biol. 2013 Jul;136:178-82. doi: 10.1016/j.jsbmb.2012.10.004. Review.

PMID:
23069645
20.

Eldecalcitol for the treatment of osteoporosis.

Matsumoto T, Endo I.

Drugs Today (Barc). 2012 Mar;48(3):189-96. doi: 10.1358/dot.2012.48.3.1745223. Review.

PMID:
22462038
Items per page

Supplemental Content

Loading ...
Support Center